Irras AB engages in the development, design, and commercialization of solutions for the treatment of brain pathologies. It offers IRRAflow, an integrated, closed-circuit medical device system that enables controlled management of cerebrospinal fluid (CSF) while providing continual monitoring of intracranial pressure (ICP). The company was founded by Christos Panotopoulos in 2012 and is headquartered in Stockholm, Sweden.
Industry:
Medical Specialties
Frequently Asked Questions